Literature DB >> 17000121

Regulation of class-switch recombination and plasma cell differentiation by phosphatidylinositol 3-kinase signaling.

Sidne A Omori1, Matthew H Cato, Amy Anzelon-Mills, Kamal D Puri, Miriam Shapiro-Shelef, Kathryn Calame, Robert C Rickert.   

Abstract

Class-switch recombination (CSR) is essential for humoral immunity. However, the regulation of CSR is not completely understood. Here we demonstrate that phosphatidylinositol 3-kinase (PI3K) actively suppressed the onset and frequency of CSR in primary B cells. Consistently, mice lacking the lipid phosphatase, PTEN, in B cells exhibited a hyper-IgM condition due to impaired CSR, which could be restored in vitro by specific inhibition of PI3Kdelta. Inhibition of CSR by PI3K was partially dependent on the transcription factor, BLIMP1, linking plasma cell commitment and cessation of CSR. PI3K-dependent activation of the serine-threonine kinase, Akt, suppressed CSR, in part, through the inactivation of the Forkhead Box family (Foxo) of transcription factors. Reduced PI3K signaling enhanced the expression of AID (activation-induced cytidine deaminase) and accelerated CSR. However, ectopic expression of AID could not fully overcome inhibition of CSR by PI3K, suggesting that PI3K regulates both the expression and function of AID.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17000121     DOI: 10.1016/j.immuni.2006.08.015

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  103 in total

Review 1.  Emergence of the PI3-kinase pathway as a central modulator of normal and aberrant B cell differentiation.

Authors:  G V Baracho; A V Miletic; S A Omori; M H Cato; R C Rickert
Journal:  Curr Opin Immunol       Date:  2011-02-01       Impact factor: 7.486

2.  14-3-3sigma regulates B-cell homeostasis through stabilization of FOXO1.

Authors:  Yu-Wen Su; Zhenyue Hao; Atsushi Hirao; Kazuo Yamamoto; Wen-Jye Lin; Ashley Young; Gordon S Duncan; Hiroki Yoshida; Andrew Wakeham; Philipp A Lang; Kiichi Murakami; Heiko Hermeking; Bert Vogelstein; Pamela Ohashi; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-04       Impact factor: 11.205

Review 3.  Molecular underpinning of B-cell anergy.

Authors:  Yuval Yarkoni; Andrew Getahun; John C Cambier
Journal:  Immunol Rev       Date:  2010-09       Impact factor: 12.988

4.  Germinal Center Selection and Affinity Maturation Require Dynamic Regulation of mTORC1 Kinase.

Authors:  Jonatan Ersching; Alejo Efeyan; Luka Mesin; Johanne T Jacobsen; Giulia Pasqual; Brian C Grabiner; David Dominguez-Sola; David M Sabatini; Gabriel D Victora
Journal:  Immunity       Date:  2017-06-20       Impact factor: 31.745

Review 5.  The conundrum of inhibitory signaling by ITAM-containing immunoreceptors: potential molecular mechanisms.

Authors:  Paul M Waterman; John C Cambier
Journal:  FEBS Lett       Date:  2010-09-28       Impact factor: 4.124

6.  The mTORC1/4E-BP/eIF4E Axis Promotes Antibody Class Switching in B Lymphocytes.

Authors:  Honyin Chiu; Leandra V Jackson; Kwon Ik Oh; Annie Mai; Ze'ev A Ronai; Davide Ruggero; David A Fruman
Journal:  J Immunol       Date:  2018-12-10       Impact factor: 5.422

7.  Suppression of phosphatidylinositol 3,4,5-trisphosphate production is a key determinant of B cell anergy.

Authors:  Cecille D Browne; Christopher J Del Nagro; Matthew H Cato; Hart S Dengler; Robert C Rickert
Journal:  Immunity       Date:  2009-11-05       Impact factor: 31.745

Review 8.  AKT/PKB Signaling: Navigating the Network.

Authors:  Brendan D Manning; Alex Toker
Journal:  Cell       Date:  2017-04-20       Impact factor: 41.582

9.  Altered FOXO1 transcript levels in peripheral blood mononuclear cells of systemic lupus erythematosus and rheumatoid arthritis patients.

Authors:  Chia-Chen Kuo; Shih-Chang Lin
Journal:  Mol Med       Date:  2007 Nov-Dec       Impact factor: 6.354

10.  Activation-induced deaminase-mediated class switch recombination is blocked by anti-IgM signaling in a phosphatidylinositol 3-kinase-dependent fashion.

Authors:  Lynn M Heltemes-Harris; Patricia J Gearhart; Paritosh Ghosh; Dan L Longo
Journal:  Mol Immunol       Date:  2007-11-05       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.